Observational studyAmerican journal of perinatology2022

Respiratory Syncytial Virus Immunoprophylaxis with Palivizumab: 12-Year Observational Study of Usage and Outcomes in Canada.

Ian Mitchell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.